<DOC>
	<DOCNO>NCT02959060</DOCNO>
	<brief_summary>This study evaluate effect rifampin single-dose pharmacokinetics ( PK ) BMS-986177 healthy participant parameter like Cmax , AUC ( INF ) , AUC ( 0-T )</brief_summary>
	<brief_title>A Study Evaluate Effect Rifampin Single-dose Pharmacokinetics BMS-986177 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>1 . Signed Informed Consent 2 . Healthy men woman ( child bear potential ) determine medical history , surgical history , physical examination , vital sign , electrocardiogram ( ECG ) , clinical laboratory test include coagulation parameter . 3 . Subjects body mass index 18 30 kg/m2 , inclusive normal kidney function . 4 . Women participant must document proof childbearing potential . 5 . Men sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment BMS986177 plus 5 halflives ( 3 day ) plus 90 day ( duration sperm turnover ) total 93 day completion BMS986177 treatment . 1 . Any significant acute chronic medical illness , include condition list contraindication rifampin package insert 2 . History recurrent headache , dizziness , chronic diarrhea , gastroesophageal reflux disease , dyspepsia , gastrointestinal ulcer disease , recurrent urinary tract infection , hypermenorrhea recurrent candida infection , abnormal bleeding , history hemophilia , Rosenthal syndrome , FXIa deficiency , coagulopathies . 3 . Recent surgery , head injury , blood transfusion , systemic lupus erythamatous , aneurysm , drug alcohol abuse use tobacco nicotine containing product past six month . 4 . Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECGs , clinical laboratory determination beyond consistent target population 5 . History allergy BMS986177 , FXIa inhibitor , rifampin related compound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>